scispace - formally typeset
D

Daniel A. Kertesz

Researcher at Health Canada

Publications -  8
Citations -  595

Daniel A. Kertesz is an academic researcher from Health Canada. The author has contributed to research in topics: Streptococcus pneumoniae & Population. The author has an hindex of 6, co-authored 8 publications receiving 589 citations.

Papers
More filters
Journal ArticleDOI

Invasive Disease Due to Group B Streptococcal Infection in Adults: Results From a Canadian, Population-Based, Active Laboratory Surveillance Study—1996

TL;DR: In 1996, a population-based surveillance program for invasive adult group B streptococcal (GBS) diseases in Canada was undertaken, to define the epidemiologic and microbiologic characteristics of the disease.
Journal ArticleDOI

Risk Factors and Course of Illness Among Children With Invasive Penicillin-resistant Streptococcus pneumoniae

TL;DR: Responses to therapy, including response to penicillin or ampicillin among children with nonmeningeal invasive disease, course of illness, and clinical outcome did not differ significantly between children infected withPenicillin-susceptible or penicillus-resistant isolates.
Journal ArticleDOI

Cruise ships: high-risk passengers and the global spread of new influenza viruses.

TL;DR: It is concluded that an "off-season" influenza outbreak occurred among international travelers and crew on board this cruise ship in 1997.
Journal ArticleDOI

Invasive Streptococcus pneumoniae Infection in Latin American Children: Results of the Pan American Health Organization Surveillance Study

TL;DR: This study emphasizes the need for local surveillance for invasive pneumococcal disease before the development and evaluation of protein-polysaccharide conjugate vaccines for children, especially in an era of increasing antimicrobial resistance.
Journal ArticleDOI

Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada.

TL;DR: Since there is no vaccine available to control serogroup B meningococcal disease, the appearance of this variant may have public-health significance if it demonstrates the same epidemic potential as its serogroups C counterpart.